Biosensors   

Is Biosensors a good buy?

Thanks Bro. allright

 

My personal view:

May be Last call!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

 

I am ONLY guessing as to the leverage of the shares . MY guess is only in answer to the postings that it is DB who is pushing down the price..As to the analyst's  positive reaction to the CEO  read below the comments which was on 24 of January 2008

DJ MARKET TALK: Biosensors New CEO Bodes Well For M&A-Analyst (2008/01/24 16:55PM) 0855 GMT [Dow Jones] Biosensors (B20.SG) off 2.4% at S$0.80 as recent strong interest, after company received coveted CE mark for its flagship BioMatrix drug-eluting stent, wanes. But Deutsche Bank analyst Pyari Madhava Menon says latest appointment of medical device veteran Michael Klein as CEO bodes well for company, may help drive up share price given his "strong track record of successfully positioning companies he led as acquisition targets." Says Biosensors may be buyout target as larger companies like Johnson & Johnson (JNJ) and Boston Scientific (BSX) - which already have stents, channels to distribute other products - may be better positioned to "unlock the best value" of Biosensors'' products; "from that perspective, we still view Biosensors as an acquisition target and the appointment of the new CEO with a track record in M&A adds more conviction to this view." Support at this week''s low of S$0.765. (FKH) Contact us in Singapore. 65 64154 150; MarketTalk@dowjones.com

 

Bro.allright,can U confirm this news...Think DB may have leveraged by now as their own analyst called

a BUY on Biosensors and welcomed the news of the new CEO Michael Kleine as positive for BIG

If confirm BIG will Mega Cheong!!!!!!!!!!!!!!!!

 

hope this continues man....good sprint :)

 

Thanks A02041315....didnt have the guts to buy at .83...hope it continues uptrend...Think DB may have leveraged by now as their own analyst called a BUY on Biosensors and welcomed the news of the new CEO Michael Kleine as positive for BIG

 

15:39:48	0.845	10,000	Buy Up
15:39:45	0.845	65,000	Buy Up
15:39:41	0.845	10,000	Buy Up
15:39:22	0.845	20,000	Buy Up
15:39:16	0.840	500,000	Buy Up
15:39:06	0.840	400,000	Buy Up
15:39:01	0.840	20,000	Buy Up
15:38:39	0.840	5,000	Buy Up
15:38:39	0.840	50,000	Buy Up

 

Warrants Name	BIOSENSORS DB ECW080623 (D9DW)	Maturity (Y-M-D)	2008-06-23
Underlying	BIOSENSORS	Last Trading Date (Y-M-D)	2008-06-17
Call/Put	CALL	Entitlement Ratio	1
Strike	0.85 (SGD)	Board Lot	1,000

D Bank block price.Excrise price 0.85

 

road block at 84 cents....real or not?

 

 

Lausk22... ;)

Maybe your wish has come true to 'ganyibeijiu' again with your 'haopengyhou'...

See you in the "Entertainments" thread...

 

Bro. allright:

Thank you ,going to CHEONG!!!!!!!!!!!!!!!!!!!!!!!SOON!!!!!!!!!!!!!!!!!!

 

page 2 (sorry don't know how to copy and paste so I had to split into 2 postings)

SINGAPORE ? HONG KONG ? INDONESIA ? LONDON ? MALAYSIA ? NEW YORK ? PHILIPPINES ? TAIWAN ? THAILAND ? VIETNAM | www.kelive.com

KELIVE

R E S E A R C H

9

?

US$10.9m vs.US$26.3m a year ago. Bottomline buoyed by

exceptional item of US$14m which relates to the settlement of a

non-recurring legal action and impairment loss for financial assets.9MFY08 revenue +31% yoy to US$32.3m and lowered net loss to

Technical Comment:

?

we believe the gap that established on 22 Jan is likely to cover.

Recommend a buy on Biosensors with a target price of $0.89.Since it managed to close above the resistance at $0.85 on 15 Feb,

?

Biosensors and Venture suggested a possible trading opportunity. It

seems to be profitable for investors to sell Venture Manufacturing

and buy Biosensors.On top of our technical call on Biosensor, the spread chart of

Biosensors (BIG SP) - Beneficiary of R&D tax deduction

Stock Information

Market Cap (S$m) 880.0

52-week high ($) 1.12

52-week low ($) 0.59

Shares issued (m) 1053.9

6m avg. daily vol (m) 7.4

Free float (%) 64.6

Major Shareholders

Yoh-Chie Lu 21%

Financial Data

Biosensor

Recommend a buy on Biosensors

Year End Mar 2005 2006 2007

Sales (US$m) 71.0 37.9 34.4

Pretax Profit (US$m) 29.1 (21.0) (35.1)

Net profit (US$m) 20.0 (22.5) (36.3)

EPS (US cts) 2.9 (2.6) (4.0)

EPS growth 45.0 n.m n.m

P/B (x) 10.9 6.9 8.8

 

ppIPppaNGAPORE ? HONG KONG ? INDONESIA ? LONDON ? MALAYSIA ? NEW YORK ? PHILIPPINES ? TAIWAN ? THAILAND ? VIETNAM | www.kelive.com

KELIVE

R E S E A R C H

8

Biosensors (BIG SP) - Beneficiary of R&D tax deduction

Singapore Budget 2008 - R&D

?

development (R&D) done in Singapore to jump from 100% to 150%

and made available from 2009 to 2013.Tax deduction for expenditure incurred on research and

?

2009 to 2013, amounting to 50% of the first S$300,000 of

chargeable income for each year.R&D Tax Allowance to grant companies R&D tax allowance from

?

Holdings, STATS ChipPac and Venture, Bio-Technological

companies such as Biosensors may also benefit.Besides Technology firms such as CSM, Creative, Ellipsiz, ASTI

?

devices such as the BioMatrix drug -eluting stent system (DES)

which received the Conformite Europeenne (CE) Mark of approval

on 18 January 2008.Biosensors develops, manufactures and commercializes medical

?

which is expected to be launched in April 2008 (1QFY09).Significant revenue contribution will derived from BioMatrix in 2H09

?

incurring an operating loss for 1H09 but a break-even position for

2H09.Management guided revenue range of US$100-US$150m for FY09,

Companies with R&D expenses

Spread Chart of Biosensor and Venture Manufacturing

Ranking Technology Sector R&D - % of sales R&D expenses ($m) Sales ($m)

1* Chartered Semiconductor Manufacturing 11.8% 159. 8 1 ,355.5

2* Creative 7.0% 6 3.6 9 14.9

3 Ellipsiz 2.9% 5 .8 2 00.6

4 ASTI Holdings 2.2% 9 .0 4 16.4

5* STATS ChipPAC 1.9% 3 0.4 1 ,616.9

6 Venture 0.8% 2 9.6 3 ,872.8

Bio-Tech Sector R&D - % of sales R&D expenses (US$m) Sales (US$m)

Biosensors 72.4% 24.9 34.4

LMA 1.2% 1.2 99.6

Source: Company data, KELive

 

Kim eng securites just called a buy on Biosensors

 

Mr Mani,

U sound hurt or petty? Unlike u leh... as I said in an earlier post. Must remember that leaving or parting is such sweet sorrow too(Shakespeare). Can U foresake your beloved gu peo da jie jie and gan bei lau peng you?

Alternatively, come back in a different alter ego, like Manymoremanicum... to entertain and be entertained again?

 

 

ehh...volume for Biosensors very low on Thursday 

 

Mani, why are you leaving? You mean you cannot stomach that post?

So now you know how others feel when you rubbed them and grin with a smiley...:))

 

If takeover in 2008 for $3, this is a short term jackpot for all. For this share to hit $3 if BIG go independent, it may take at least 3 more years from now (when biomatrix's USA FDA approval is almost in sight). After FDA approval, share price will definitely cross $3. When BIG becomes a true blue global DES powerhouse say 5 years later, crossing $5 is not a problem. But any thing can happen along the way........ like another better DES company emerge??? But so far no better DES company in sight yet. All claim to be revolutionary but not proven yet. I think BIG's current DES technology can dominate this industry for another good 10 years. BIG biomatrix's clinical results are really very hard to beat even years down the road. It will be an industry benchmark.    

 

Greetings Bengster San

 Thank you for the explanation. Looks like there is a good chance of this happening. Just when and who

 SM